Company intelligence / Profile preview

Rayscape

Timisoara, Timiș, Romaniarayscape.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Rayscape has developed and deployed advanced artificial intelligence solutions that assist radiologists by improving the accuracy and efficiency of X-ray and CT scan interpretation. Their products are used globally with over 44 million images analyzed to train their algorithms. Clinical evidence supports high precision in lung nodule detection and workflow integration. No traditional clinical trial results as it’s a software/device company.

Therapeutic areas: OncologyPulmonology
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

No specific major pharma or biotech partnerships listed; focus on hospital/radiology group integrations.

Beyond the preview

Go deeper on Rayscape.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rayscape.

Explore the full profile